RecruitingNCT07056374

Adaptive Anastomosis for Anterior Resection in Sigmoid and Proximal Rectal Cancer or Premalignant Lesions

Adaptive Anastomosis for Anterior Resection in Sigmoid and Proximal Rectal Cancer or Premalignant Lesion: a Multicentre Non-randomised Clinical Effectiveness Trial )ADAPT


Sponsor

Amsterdam UMC, location VUmc

Enrollment

165 participants

Start Date

Mar 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Anastomotic leakage (AL) after colorectal surgery remains a significant challenge, associated with increased morbidity, mortality, poor oncological outcomes, and reduced quality of life. Despite surgical advances, AL rates for colorectal procedures continue to range from 3% to 25%, especially in distal anastomoses. The commonly used cross-stapled circular anastomosis for anterior resections (AR) activates a foreign body response delaying gastrointestinal wound healing and potentially increasing the risk of AL. Additionally, crossed stapler lines further increase the risk of AL. An adaptive anastomosis technique eliminates permanent foreign body material, thereby reducing negative effects on wound healing and avoiding cross-stapling potentially lowering the incidence of AL. These areas have shown to have a lower burst pressure compared to a single stapled anastomosis. An adaptive anastomotic technique eliminates cross-stapling and permanent foreign body material in the anastomosis reducing the negative effects on wound healing potentially lowering the incidence of AL. Design: This is a prospective, international, non-randomized, multicentre study. Endpoints: The Primary objective of this trial is to assess the incidence of AL within 30 days after surgery. Secondary objectives are to assess anastomotic integrity at 90 days and 1 year, intraoperative efficacy and efficiency of the C-REX device, time to evacuation of the anastomotic ring, mode of evacuation and related patient experience, postoperative morbidity and readmissions, C-reactive protein (CRP) profile in the early postoperative period, functional outcomes, cost-effectiveness and surgical quality. Population: A total of 165 patients (age ≥ 18 years) with histologically proven cT1-4aN0-2M0 cancer of the sigmoid colon or proximal rectum, or premalignant lesions not amenable to endoscopic resection, that require elective AR will be enrolled throughout 10 European colorectal centers. Study procedures: The anastomosis will be created using the C-REX RectoAid Cath. The healing period will be approximately 10 days. The anastomotic ring detaches via necrosis and is evacuated with the feces. Patients will be asked to fill out questionnaires regarding Low Anterior Resection Syndrome (LARS) and use of healthcare and these will be gathered preoperatively, 90 days postoperative and 1 year after surgery. At 12 months a CT-scan and colonoscopy will be performed.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial tests an "adaptive anastomosis" technique — a new surgical approach for connecting the bowel after removing part of the sigmoid colon or upper rectum for cancer or large precancerous polyps. The technique is designed to reduce the risk of the bowel connection leaking, which is one of the most serious complications of this type of surgery. It uses a temporary gel to protect the join while it heals. **You may be eligible if...** - You have cancer or a large precancerous growth in your sigmoid colon or upper rectum that requires surgical removal - Your cancer has not spread to distant organs (no stage IV cancer) - You are suitable for planned (non-emergency) laparoscopic or robotic surgery - You are able to understand and consent to the study **You may NOT be eligible if...** - You need emergency surgery (e.g., for blocked or perforated bowel) - Your cancer has spread to other organs - You have previously received pelvic radiotherapy - You need a temporary ileostomy (a bag on the abdomen to divert waste while the bowel heals) - You are immunocompromised or have other conditions that increase surgical risk Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEC-REX RectoAid Cath

Adaptive anastomotis


Locations(1)

Amsterdam UMC

Amsterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07056374


Related Trials